510(k) · Cleared
Recalled · Class II · 2016Vitros Immunodiagnostic Products Total B-HCG II Reagent Pack, Calibrators, Range Verifiers
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Ortho-Clinical Diagnostics · DHA System, Test, Human Chorionic Gonadotropin
Cleared on Apr 9, 2007 as substantially equivalent to K983424 (Abbott Laboratories, 1998) and 2 other predicates after a 115-day review. Its family tree reaches back 1 generation to 1997. 1 later device descends from it. It has been recalled once.
- Decided
- Apr 9, 2007
- Review
- 115 days
- Class
- Class II
- Product code
- DHA
- Recalls
- 1
- Predicates
- 3
Its longest line of descent runs back 1 generation to K970894 (1997). 3 ancestors in all. 1 later device descends from it, 1 citing it directly.
- Root · 1 generation backK970894 Vitros Immunodiagnostics Products Total B-HCG Reagent Pack…Johnson & Johnson Clinical Diagnostics, Inc. · 1997
- This deviceK063720 Vitros Immunodiagnostic Products Total B-HCG II Reagent Pack…Ortho-Clinical Diagnostics · 2007
- Descendant · cites it directly · 0 of its ownK233581 VITROS Immunodiagnostic Products Total ß-hCG II Reagent PackOrtho Clinical Diagnostics · 2024
Most influential descendants
Showing 1 of 1 · See all- K233581VITROS Immunodiagnostic Products Total ß-hCG II Reagent PackOrtho Clinical Diagnostics · 2024 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K970894 | Vitros Immunodiagnostics Products Total B-HCG Reagent Pack (Gem.1075), Total… | Johnson & Johnson Clinical Diagnostics, Inc. | 1997 | — |
| 0 (this device) | K063720 | Vitros Immunodiagnostic Products Total B-HCG II Reagent Pack, Calibrators… | Ortho-Clinical Diagnostics | 2007 | — |
| +1 | K233581 | VITROS Immunodiagnostic Products Total ß-hCG II Reagent Pack | Ortho Clinical Diagnostics | 2024 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2024 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DHA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DHA device
- #1 K233581 VITROS Immunodiagnostic Products Total ß-hCG…score 7.6 · 2 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K983424 | Abbott Archeitect Total B-HCGSummary page 2…VITROS Imnimunodiagnostic Products Total [- hCG II Range Verifiers are substantially equivalent to the Abbott Laboratories, ARCHITECT® SYSTEM Total j3-HCG assay (K983424) and VITROS Immunodiagnostic Products Total [-hCG Range Verifiers (K970894). 5 Device Description The VITROS Immunodi… | 1998 |
| * | K970894 | Vitros Immunodiagnostics Products Total B-HCG Reagent Pack (Gem.1075), Total B-HCG…Summary page 2…tantially equivalent to the Abbott Laboratories, ARCHITECT® SYSTEM Total j3-HCG assay (K983424) and VITROS Immunodiagnostic Products Total [-hCG Range Verifiers (K970894). 5 Device Description The VITROS Immunodiagnostic System uses luminescence as the signal in the quantitative and sem… | 1997 |
| * | K973517 | Vitros Immunodiagnostic Products Range VerifiersSummary page 3…lly equivalent to the Abbott Laboratories, ARCHITECT® SYSTEM Total 13-HCG assay (K983424) assay and VITROS Immunodiagnostic Products Total 3-hCG Range Verifiers (K973517). Tables I through 4 compare the VITROS Immunodiagnostic Products Total f3- hCG II assay and Range Verifiers to the Abbot… | 1997 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K233581 | VITROS Immunodiagnostic Products Total ß-hCG II Reagent Pack | 2024 | 0 |
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Feb 18, 2016 | Class II | Z-1700-2016 | Under Investigation by firm | When testing was conducted using certain lots, VITROS¿ Systems generated results within the measuring range for samples known to not contain measurable hCG. The system reported results up to approximately 7.40 mIU/mL (IU/L) for patient… |
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All DHA devicesDHA System, Test, Human Chorionic Gonadotropin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · DHA
1in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · DHA
63in 2023
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · DHA
2in 2022
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · DHA
234in 2025
MAUDE reports naming product code DHA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 64 |
| 2008 | 1 | — | 0 | 99 |
| 2009 | 1 | — | 0 | 196 |
| 2010 | 0 | — | 2 | 179 |
| 2011 | 0 | — | 0 | 478 |
| 2012 | 0 | — | 0 | 277 |
| 2013 | 2 | — | 0 | 244 |
| 2014 | 0 | — | 0 | 119 |
| 2015 | 1 | — | 2 | 52 |
| 2016 | 0 | — | 0 | 55 |
| 2017 | 2 | — | 0 | 101 |
| 2018 | 0 | — | 1 | 103 |
| 2019 | 1 | — | 0 | 152 |
| 2020 | 1 | — | 0 | 115 |
| 2021 | 3 | 289 | 0 | 210 |
| 2022 | 1 | — | 2 | 185 |
| 2023 | 3 | 63 | 0 | 194 |
| 2024 | 1 | — | 0 | 261 |
| 2025 | 0 | — | 0 | 234 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
For quantitative measurement of human chorionic gonadotropin (hCG) and its n-subunit in human serum and plasma (EDTA or heparin) to aid in the early detection of pregnancy.
For use in the calibration of the VITROS Immunodiagnostic System for the quantitative measurement of human chorionic gonadotropin (hCG) and its [-subunit in human serum and plasma (EDTA or heparin).
For in vitro use in verifying the calibration range of the VITROS Immunodiagnostic System when used for the measurement of human chorionic gonadotropin (hCG) and its [-subunit.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K063720 · printed Nov 5, 2026
Cite this page
510(k) Report. “K063720: Vitros Immunodiagnostic Products Total B-HCG II Reagent Pack, Calibrators, Range Verifiers.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K063720
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026